The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II prospective, open-label, multi-center, single-arm study of sasanlimab plus sacituzumab govitecan in BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) pts: SSANTROP (APRO07-2022).
 
Joaquim Bellmunt
Stock and Other Ownership Interests - Rainier Therapeutics
Honoraria - UpToDate
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; EMD Serono/Merck; Merck; Novartis; Pfizer; Pierre Fabre
Research Funding - Pfizer/EMD Serono (Inst); Pfizer/Gilead
Patents, Royalties, Other Intellectual Property - UpToDate Bladder Cancer
Travel, Accommodations, Expenses - Genentech/Roche; Ipsen
 
Alejo Rodríguez-Vida
No Relationships to Disclose
 
Imanol Martinez
No Relationships to Disclose
 
María José Méndez-Vidal
No Relationships to Disclose
 
Carlos Gonzalez
Honoraria - Astellas Oncology; Ipsen; Janssen
Research Funding - AstraZeneca (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - Astellas Oncology; Bayer; Casen Recordati; Ipsen; Janssen; ROVI
 
Carlos Alvarez-Fernandez
Consulting or Advisory Role - AstraZeneca; Bayer; Merck/Pfizer; Pfizer
Travel, Accommodations, Expenses - Ipsen; Pfizer; Roche
 
Nuria Sala González
Consulting or Advisory Role - Bristol-Myers Squibb; Pfizer; Roche
Speakers' Bureau - Astellas Oncology; Ipsen
 
Oscar Buisan
No Relationships to Disclose
 
Maria Jose Miranda Pallares
No Relationships to Disclose
 
Pablo Gajate
Consulting or Advisory Role - Astellas Pharma; BMS; Ipsen; Janssen Oncology; Merck; MSD; Novartis; Pfizer; Roche
Speakers' Bureau - Astellas Pharma; BMS; IPSEN; Merck; MSD; Pfizer; Roche
Travel, Accommodations, Expenses - Ipsen; Merck; Pfizer; Roche
 
Ovidio Fernández
No Relationships to Disclose
 
Julio Lambea- Sorrosal
No Relationships to Disclose
 
José García Sánchez
Consulting or Advisory Role - Boehringer Ingelheim; Eisai Europe; EUSA Pharma; PharmaMar; Roche; Sanofi
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer; Roche
 
Daniel Castellano Gauna
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Ipsen; Janssen Oncology; Lilly; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; Sanofi
Research Funding - Janssen Oncology (Inst)
Travel, Accommodations, Expenses - AstraZeneca Spain; Bristol-Myers Squibb; Novartis; Pfizer; Roche
 
Elena Sevillano
Honoraria - Astellas Pharma; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb/Sanofi
Research Funding - Pfizer
 
Martín Lázaro
No Relationships to Disclose
 
Federico Vazquez Mazon
No Relationships to Disclose
 
Pablo Maroto-Rey
Consulting or Advisory Role - Astellas Pharma; Bayer; BMS; Ipsen; Janssen; Merck/Pfizer; MSD
Expert Testimony - Amgen
Travel, Accommodations, Expenses - Bayer; Ipsen; Merck/Pfizer
 
Enrique Gallardo
No Relationships to Disclose
 
Oscar Rodriguez Faba
No Relationships to Disclose